Published in BMJ on September 29, 2001
Are guidelines ethical? Some considerations for general practice. Br J Gen Pract (2002) 1.30
The 'NICE' approach to technology assessment: an economics perspective. Health Care Manag Sci (2004) 1.25
Evidence based medicine guidelines: a solution to rationing or politics disguised as science? J Med Ethics (2004) 1.17
Review of Australian health economic evaluation - 245 interventions: what can we say about cost effectiveness? Cost Eff Resour Alloc (2008) 1.14
Research ethics and evidence based medicine. J Med Ethics (2004) 0.90
NICE guidance: a comparative study of the introduction of the single technology appraisal process and comparison with guidance from Scottish Medicines Consortium. BMJ Open (2012) 0.88
National guidance and allocation of resources. Acting chairman of SIGN's response. BMJ (2002) 0.75
National guidance and allocation of resources. Economics has both strengths and weaknesses in health resource allocation. BMJ (2002) 0.75
Is there a tension between doctors' duty of care and evidence-based medicine? Health Care Anal (2002) 0.75
The failings of NICE. BMJ (2000) 8.50
The failings of NICE. Reply from chairman of NICE. BMJ (2001) 2.55
Flu drug still not worth prescribing, experts say. BMJ (2001) 1.35
Regulating the pharmaceutical industry. BMJ (1997) 6.61
Rationing health care. BMJ (1996) 5.27
Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am J Physiol Lung Cell Mol Physiol (2008) 3.80
Promoting cost effective prescribing. BMJ (1995) 3.46
Can general practitioners counsel? J R Coll Gen Pract (1989) 2.88
The doctor, the patient, and their contract. III. Alternative contracts: are they viable? Br Med J (Clin Res Ed) (1986) 2.86
The doctor, the patient, and their contract. I. The general practitioner's contract: why change it? Br Med J (Clin Res Ed) (1986) 2.70
Something rotten in the state of clinical and economic evaluations? Health Econ (1994) 2.50
Rewarding healthcare teams. BMJ (1998) 2.47
The doctor, the patient, and their contract. II. A good practice allowance: is it feasible? Br Med J (Clin Res Ed) (1986) 2.36
Applying resource allocation formulae to constituent parts of the U.K. Lancet (1980) 2.34
On the way to Calvary. Ministers should realise the command and control model the white paper entails. BMJ (1998) 2.30
Data Note--9. Measuring the social costs of addictive substances. Br J Addict (1987) 2.09
Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. I. Retransplantation of (AS X AUG)F1 kidneys into secondary AS recipients. J Exp Med (1979) 1.88
Efficiency in the National Health Service: lessons from abroad. Health Policy (1988) 1.79
Economic aspects of tobacco use and taxation policy. BMJ (1988) 1.70
Doctors have no time for alcohol screening. Br Med J (Clin Res Ed) (1987) 1.63
The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project. Int J Geriatr Psychiatry (2010) 1.61
Private finance for the public good? BMJ (1996) 1.56
Regional distribution of family practitioner services: implications for National Health Service equity and efficiency. J R Coll Gen Pract (1987) 1.41
The costs of alcohol misuse. Br J Addict (1985) 1.32
Lessons from international experience in controlling pharmaceutical expenditure. III: Regulating industry. BMJ (1996) 1.30
The mental health services: a review of the statistical sources and a critical assessment of their usefulness. Br J Psychiatry (1974) 1.29
Medical manpower in the year 2000. Br Med J (1979) 1.23
Development of a social inclusion index to capture subjective and objective life domains (Phase II): psychometric development study. Health Technol Assess (2012) 1.17
Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins. J Med Chem (1998) 1.14
Estimation of life years lost from alcohol-related premature death. Alcohol Alcohol (1985) 1.13
Morbidity variation and RAWP. J Epidemiol Community Health (1990) 1.11
New Zealand's new health sector reforms: back to the future? BMJ (2001) 1.10
An outsider's view of the NHS reforms. BMJ (1994) 1.10
Teaching health economics. Br Med J (Clin Res Ed) (1986) 1.09
Skill mix changes: substitution or service development? Health Policy (1998) 1.04
Financing the U.K. national health services. Health Policy (1986) 1.02
Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers. J Med Chem (1999) 0.99
Case for auditing audit. Health Serv J (1991) 0.97
Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 Co-receptor and ligand binding function. J Biol Chem (1999) 0.96
Financing health care in Europe: context for the Schizophrenia Outpatient Health Outcomes Study. Acta Psychiatr Scand Suppl (2003) 0.92
Ethics and health care 'underfunding'. J Med Ethics (2001) 0.92
Determining value for money in day hospital care for the elderly. Age Ageing (1986) 0.90
Health care reform. Health Econ (1998) 0.89
Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practices. Aliment Pharmacol Ther (2000) 0.89
A nice challenge for health economics. Health Econ (2000) 0.88
Who will die and who will survive? Health Serv J (1988) 0.88
Private practice: answer or irrelevance? Br Med J (Clin Res Ed) (1984) 0.86
Translating evidence into practice. The case of influenza vaccination. Eur J Public Health (2001) 0.84
Economic aspects of addiction policy. Health Promot (1986) 0.84
Public opinion and rationing in the United Kingdom. Health Policy (1999) 0.83
Public and private sector interactions: an economic perspective. Soc Sci Med (1986) 0.83
Doctors and alcohol screening--the gap between attitudes and action. Health Educ J (1988) 0.83
A comparison of the costs and benefits of recombinant human erythropoietin (epoetin) in the treatment of chronic renal failure in 5 European countries. Pharmacoeconomics (1992) 0.82
Costs of dementia in Hungary. J Nutr Health Aging (2010) 0.82
What is to be done about fundholding? BMJ (1997) 0.81
Ethics and journal publishing: taking the debate forward. Ethics and the incentive structure. Addiction (1995) 0.80
The state of the art in European research on reducing social exclusion and stigma related to mental health: a systematic mapping of the literature. Eur Psychiatry (2014) 0.80
The relevance of health economics to health promotion. WHO Reg Publ Eur Ser (1991) 0.79
Are drug policies based on 'fake' statistics? Addiction (1993) 0.79
Evidence based medicine. Cost effectiveness and equity are ignored. BMJ (1996) 0.79
Polymorphism in the promoter region of HLA-DRB genes. Hum Immunol (1993) 0.78
Is there scope for improving the cost-effective prescribing of nonsteroidal anti-inflammatory drugs? Pharmacoeconomics (1996) 0.78
Thoracic size-selective sampling of fibres: performance of four types of thoracic sampler in laboratory tests. Ann Occup Hyg (2005) 0.77
The economics of addiction: the role of the economist in addictions research. Br J Addict (1989) 0.77
The market reform of the New Zealand health care system searching for the Holy Grail in the Antipodes. Health Policy (1994) 0.77
Ibuprofen versus other non-steroidal anti-inflammatory drugs: use in general practice and patient perception. Aliment Pharmacol Ther (2000) 0.77
Regulation of anti-hapten antibody responses in vivo: memory, carrier-specific Lyt-2+ T cells can terminate antibody production without altering the peak of response. J Immunol (1984) 0.76
Evaluating health interventions in the 21st century: old and new challenges. Health Policy (2003) 0.76
Inequalities in health: an introduction. Health Econ (1999) 0.75
Health care reform in the United States. Health Econ (1992) 0.75
Politicians may not have same goals as clinicians with regard to mergers. BMJ (1999) 0.75
Electronic bibliographic tools for incorporating social science research into health care must be improved. BMJ (1999) 0.75
Drug information and cost effectiveness. Br Med J (1979) 0.75
Fundholding and prescribing. Prescribing practice may have been inefficient. BMJ (1995) 0.75
Hospital and community health service costs: England and Scotland compared. Br Med J (Clin Res Ed) (1988) 0.75
Limits to demand for health care. Rationing is needed in a national health service. BMJ (2001) 0.75
Nursing shortages. Pay increases are most efficient response to labour shortages. BMJ (1996) 0.75
Secrecy in the NHS. Clinicians should not restrict access to basic information. BMJ (1995) 0.75
Avarice, inefficiency, and inequality: an international health care tale. Int J Health Serv (1977) 0.75
The cost of our neglect. Health Serv J (1987) 0.75
Counting the cost of alcohol: gaps in epidemiological knowledge. Community Med (1985) 0.75
Budgeting in health care systems. Eff Health Care (1984) 0.75
Who cares about the NHS? Health Serv J (1987) 0.75
Addiction Research Centre: Hull-York, U.K. Br J Addict (1987) 0.75
Community care. Health Serv J (1986) 0.75
Data note--2. Measuring U.K. alcohol and tobacco consumption. Br J Addict (1986) 0.75
Flawed above. Nurs Manag (Harrow) (1994) 0.75
Geriatric day hospitals on trial. Health Soc Serv J (1985) 0.75
An economic exploration of oral and intravenous ganciclovir in the induction and maintenance treatment of AIDS-related cytomegalovirus retinitis. Int J STD AIDS (1996) 0.75
Knowledge based--not blindly biased. Nurs Manag (Harrow) (1994) 0.75
Date note--5. The consumption of illicit drugs in the U.K. Br J Addict (1986) 0.75
What nursing shortage? Health Serv J (1987) 0.75
Numbers nonsense. Nurs Manag (Harrow) (1994) 0.75
Fetal cocaine exposure and neonatal bilirubinemia. J Pediatr (1994) 0.75
Minimal access surgery. Through the keyhole. Health Serv J (1994) 0.75
Should trusts be allowed to fail? BMJ (1997) 0.75
Addiction control policies or there's no such thing as a free lunch. Br J Addict (1985) 0.75
Performance indicators and performance assessment in the UK National Health Service: implications for management and planning. Int J Health Plann Manage (1986) 0.75
Primary care. Reassessing NHS evaluation could prove a "blooming" success. Health Soc Serv J (1984) 0.75
Maintaining the status quo for consultants' contracts--the case for the attack. Health Serv Manpow Rev (1987) 0.75
Incentives for cost-effective physician behavior. Health Policy (1987) 0.75